CytomX Therapeutics Inc (CTMX)

4.48 -0.65 (-12.67%) USD  |  NASDAQ  |  May 02, 16:00
4.50 +0.02 (+0.45%) After-Hours: 20:00
More

CytomX Therapeutics Cash and Short Term Investments (Quarterly): 174.51M for Dec. 31, 2023

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2014. Upgrade now.
Date Value
December 31, 2023 174.51M
September 30, 2023 194.11M
June 30, 2023 180.86M
March 31, 2023 204.50M
December 31, 2022 193.65M
September 30, 2022 194.29M
June 30, 2022 228.16M
March 31, 2022 262.53M
December 31, 2021 305.23M
September 30, 2021 236.29M
June 30, 2021 266.18M
March 31, 2021 393.80M
December 31, 2020 316.12M
September 30, 2020 321.08M
June 30, 2020 346.40M
March 31, 2020 247.92M
December 31, 2019 296.14M
September 30, 2019 325.71M
Date Value
June 30, 2019 349.14M
March 31, 2019 396.60M
December 31, 2018 436.13M
September 30, 2018 464.56M
June 30, 2018 335.15M
March 31, 2018 361.48M
December 31, 2017 374.11M
September 30, 2017 331.28M
June 30, 2017 335.92M
March 31, 2017 162.52M
December 31, 2016 181.94M
September 30, 2016 178.46M
June 30, 2016 195.80M
March 31, 2016 180.64M
December 31, 2015 186.71M
September 30, 2015 113.69M
June 30, 2015 125.37M
December 31, 2014 64.40M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

174.51M
Minimum
Dec 2023
393.80M
Maximum
Mar 2021
265.09M
Average
262.53M
Median
Mar 2022

Cash and Short Term Investments (Quarterly) Benchmarks

Ocular Therapeutix Inc 195.81M
Bristol-Myers Squibb Co 9.67B
ACADIA Pharmaceuticals Inc 438.86M
Cytokinetics Inc 614.82M
Calidi Biotherapeutics Inc 1.949M